Evidence map›Paper›PMID 37362161›Full record

ArticleClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology2023

A case of hyperphosphatemic familial tumoral calcinosis due to maternal uniparental disomy of a

Naoko Nishimura-Kinoshita, Yasuhisa Ohata, Hiromi Sawai, Masako Izawa, Shinji Takeyari, Takuo Kubota, Yosuke Omae, Keiichi Ozono, Katsushi Tokunaga, Takashi Hamajima

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Naoko Nishimura-KinoshitaDepartment of Pediatrics, Tango Central Hospital, Kyoto, Japan.
Yasuhisa OhataDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Hiromi SawaiDepartment of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Masako IzawaDepartment of Endocrinology and Metabolism, Aichi Children's Health and Medical Center, Aichi, Japan.
Shinji TakeyariDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Takuo KubotaDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Yosuke OmaeDepartment of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Keiichi OzonoDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Katsushi TokunagaDepartment of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Takashi HamajimaDepartment of Endocrinology and Metabolism, Aichi Children's Health and Medical Center, Aichi, Japan.
Osaka University · JPThe University of Tokyo · JPKyoto City Hospital · JPNational Center for Global Health and Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare, inherited autosomal recessive disorder caused by fibroblast growth factor-23 (

Indexed as

hyperostosis–hyperphosphatemia syndromehyperphosphatemic familial tumoral calcinosisN-acetylgalactosaminyltransferase 3 (GALNT3)tumoral calcinosisuniparental disomy

Identifiers

PMID37362161
PMCPMC10288290
OpenAlexW4365799076

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.